"the approach. will be targeted to a specific pathogen, but It Is applicable to several different pathogens. For example, an approach may be used to develop therapeutics against 20 different pathogens"
3. Professor Ron Taylor
This project started in May 1996 at the University of Virginia. Taylor and his colleagues developed a heteropolymer that functions on the one end to connect to the CR 1 site of the red blood cells, while the other end is tailored to the specific pathogen.
4. Mesenchymal Stem Cells
DARPA also funded research into mesenchymal stem cells (MSCs) modified to have surface receptors designed for specific pathogens. When pathogen is detected, part of cell's DNA Is turned on to produce a gene protein product targeted to kill the pathogen
5. Strategy
To address specific Biological warfare agents, we will fund work at facilities such as USAMRIID, where actual bioagents are. kept. to determine If the therapeutics are effective In animal models.
6. Pharmaceutical Industry
DARPA will provide the thrust & the biotech industry & pharmaceutical industries will take over these products (clinical testing & development) to commercialize them for their own purposes.
DoD will then procure them via "normal" commercial routes
7. Unconventional Pathogen Countermeasures
"The most sinister offensive biological warfare scenario employs surprise, Immediate proximity &
rapidly lethal, persistent agents in overwhelming quantities"
BAA 97-23 Pathogen Countermeasures
Program Manager: CPR Shaun Jones, MD,USN
8. Advanced. Diagnostics
Program Manager: Dr. Stephen Morse
BAA 97-24 Advanced Diagnostics for Pathogens
9. Red Blood Cell Pathogen Decoy & Destruction
University of Virginia
Boston University - Mark Bitensky birensky@enra.bu.etlu
10. Sequential Auto Vaccination by Stem Cells
Daniel R. Marshak
dmarshak@osiristx.com
OSIRIS Therapeutics, Inc. .
Baltimore, MD
You have a radically new idea for fighting pathogens that colleagues are dubious about
Where would you go for funding?
To the NIH?
NIH would ask a committee of peers to evaluate it who can be brutal about radical concepts
12. Scripps - DARPA - Lerner
Richard Lerner, president of The Scripps Research Institute, another DARPA adviser, notes that the agency needs to keep in mind that ''you never know what you want to discover until you discover it."
DARPA was unable to locate any documents concerning "human cellular platforms used for biological warfare therapy," as you requested.
DARPA advises that this division does not exist, nor does DARPA have such a research program
14.Synthetic Polio
DARPA failed to inform anyone that one of its “unconventional” projects was $US300,000 ($393,939) to fund a trio of scientists who thought it would be a neat idea to synthesise polio.
They constructed the virus using its genome sequence, which was available on the Internet, and obtained the genetic material from companies that sell made-to-order DNA.
But building up the long chain of DNA from smaller pieces proved frustratingly difficult. Eventually, Dr. Cello simply ordered most of the completed sequence from a scientific supply house, Integrated DNA Technologies of Coralville, Iowa
DARPA provided $300K over the last 3 years for the work
''Understanding the process of viral DNA production is key to identifying new ways to kill viruses & understand how viruses could change & escape from vaccines"
Unfortunately, there is no direct proof provided by Redfield in this new interview, but he cites engineering features, early data, and classified information.
🧵3. Summary of Redfield's Statements
(on SARS-CoV-2 Origins & Cover-Up)
He claims SARS-CoV-2 originated from GOF research in a lab and emphasizes a significant US role alongside China.
He views this as a major biosecurity failure with ongoing suppression of transparency.
"Of note, the spike protein of this novel bat coronavirus possesses a functional FCS at the S1/S2 junction with a unique amino acid sequence motif (RDAR) that differs from that found in SARS-CoV-2 (RRAR) by only 1 amino acid."
"The molecular biology capabilities of WIV & the genome assessment are consistent with the hypothesis that SARS-CoV-2 was a lab-engineered virus that was part of a bank of chimeric viruses in Zheng-Li Shi's laboratory at WIV that escaped from containment"
Between 2017 and 2019, WIV created full-length a infectious clone in pBAC-CMV using an unpublished bat Coronavirus genome as template (BatCoVX)
page 85
3. Hypothesis 3:
Between 2017 and 2019, WIV created chimeric Bat-CoV-X viruses using the pBACCMV-BCOVX backbone and swapping out key cassettes with other bat Coronaviruses (RBD, RBM, etc.) and adding additional features such as a furin cleavage site
We need to find out why Peter Daszak & EcoHealth had In-Q-Tel backing and why Nathan Wolfe (an obvious intelligence asset with links to Epstein/Maxwell, Boris Nikolic, and Bill Gates) was on their editorial board.